Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European Access Academy
Elaine Julian(Edelweiss Connect (Switzerland)), Jörg Ruof(Medizinische Hochschule Hannover), Fabrizio Gianfrate(University of Ferrara), Heiner C. Bucher(University of Basel), Mondher Toumi(Aix-Marseille Université), Oriol Solà-Morales, Ansgar Hebborn(European Federation of Pharmaceutical Industries and Associations), Tomas Salmonson, Jean‐François Bergmann(Northern General Hospital), Christian Dierks, Mathilde Grande, Mira Pavlovic, Wolfgang Greiner(Bielefeld University), Antonella Cardone(European CanCer Organisation), Peter G. M. Mol(University Medical Center Groningen)
Cited by 13
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476